One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.

Détails

ID Serval
serval:BIB_76B179B1EF9C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.
Périodique
Alzheimer’s research & therapy
Auteur(s)
Dayon Loic, Guiraud Seu Ping, Corthesy John, Da Silva Laeticia, Migliavacca Eugenia, Tautvydaite Domile, Oikonomidi Aikaterini, Moullet Barbara, Henry Hugues, Metairon Sylviane, Marquis Julien, Descombes Patrick, Collino Sebastiano, Martin Francois-Pierre J., Montoliu Ivan, Kussmann Martin, Wojcik Jerome, Bowman Gene L., Popp Julius
ISSN
1758-9193
Statut éditorial
Publié
Date de publication
06/2017
Volume
9
Numéro
1
Pages
43
Langue
anglais
Résumé
BACKGROUND: Hyperhomocysteinemia is a risk factor for cognitive decline and dementia, including Alzheimer disease (AD). Homocysteine (Hcy) is a sulfur-containing amino acid and metabolite of the methionine pathway. The interrelated methionine, purine, and thymidylate cycles constitute the one-carbon metabolism that plays a critical role in the synthesis of DNA, neurotransmitters, phospholipids, and myelin. In this study, we tested the hypothesis that one-carbon metabolites beyond Hcy are relevant to cognitive function and cerebrospinal fluid (CSF) measures of AD pathology in older adults. METHODS: Cross-sectional analysis was performed on matched CSF and plasma collected from 120 older community-dwelling adults with (n = 72) or without (n = 48) cognitive impairment. Liquid chromatography-mass spectrometry was performed to quantify one-carbon metabolites and their cofactors. Least absolute shrinkage and selection operator (LASSO) regression was initially applied to clinical and biomarker measures that generate the highest diagnostic accuracy of a priori-defined cognitive impairment (Clinical Dementia Rating-based) and AD pathology (i.e., CSF tau phosphorylated at threonine 181 [p-tau181]/beta-Amyloid
Mots-clé
Humans, Female, Male, Risk Factors, Aged, Alzheimer Disease/*cerebrospinal fluid/diagnosis/*epidemiology, Alzheimer’s disease, Biomarkers/blood/cerebrospinal fluid, Carbon Compounds, Inorganic/*cerebrospinal fluid, Carbon/*blood, Cognition, Cognition Disorders/*cerebrospinal fluid/diagnosis/*epidemiology, Comorbidity, CSF, Homocysteine, Homocysteine/*cerebrospinal fluid, Metabolomics, One-carbon metabolism, Prevalence, S-adenosyl-L-homocysteine, Switzerland/epidemiology, Tau
Pubmed
Création de la notice
19/02/2020 13:23
Dernière modification de la notice
20/02/2020 7:26
Données d'usage